EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Fetal growth-guided management of gestational diabetes: A retrospective cohort study on insulin requirements and perinatal outcomes

Serena Xodo, Andrea Da Porto, Maria De Martino, Annalaura Del Pin, Asia Flaiban, Silvia Galasso, Sara Piccini, Lorenza Driul

Archives of Gynecology and Obstetrics · 21.05.2026 · 313 (1)

DOI: 10.1007/s00404-026-08467-3 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Archives of Gynecology and Obstetrics, online erschienen am 21.05.2026. Verfasst von Serena Xodo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Obstetrics and Gynecology, Santa Maria Della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy. …. Hauptthemen laut MEDLINE: Diabetes, Gestational, Insulin, Hypoglycemic Agents, Fetal Development. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Udine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate whether a fetal growth-guided management strategy can reduce treatment intensity without compromising maternal and neonatal outcomes in women with gestational diabetes mellitus (GDM).

Methods

This retrospective cohort study with propensity score matching was conducted at a single tertiary referral center and included 343 women with GDM diagnosed after a second-trimester OGTT, of whom 244 were included in the matched analysis. Participants were managed either with a fetal growth-guided approach, in which glycemic targets and insulin therapy were tailored according to fetal abdominal circumference (AC), or with standard glycemia-based care. In the growth-guided group, stricter targets were applied when AC exceeded the 70th percentile. Outcomes were analyzed in the overall cohort and after matching. Primary outcomes were insulin use and glycemic control. Secondary outcomes included maternal weight gain, obstetric outcomes, and neonatal outcomes such as birthweight, Apgar score, cord blood pH, and size for gestational age.

Results

In the overall cohort, fetal growth-guided management was associated with lower birthweight (3470 g vs 3544 g; p = 0.036), reduced basal insulin use (58% vs 83%; p < 0.001), lower total insulin dose at delivery (9 vs 18 IU; p < 0.001), and slightly improved glycemic control. After propensity score matching, basal insulin use (65% vs 80%; p = 0.029) remained lower, while glycemic control, obstetric outcomes, and neonatal outcomes were comparable. The sensitivity analysis restricted to insulin-treated patients ahowed no significant differences between the differently managed groups of patients.

Conclusions

A fetal growth-guided approach to GDM management reduces insulin requirements without worsening maternal or neonatal outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalInsulinHypoglycemic AgentsFetal DevelopmentHumansFemalePregnancyRetrospective StudiesAdultBirth WeightPregnancy OutcomeInfant, NewbornPropensity ScoreBlood Glucose

Stichwörter der Autor:innen

Fetal abdominal circumferenceGestational diabetesInsulin therapyPersonalized therapyUltrasonographic fetal growth

Substanzen

InsulinHypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • Clinic of Obstetrics and Gynecology, Santa Maria Della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy. serena.xodo@gmail.com.
  • Department of Internal Medicine, Diabetes and Metabolism Unit, Health Integrated Agency of Friuli Centrale, 33100, Udine, Italy.
  • Department of Medical Area, University of Udine, Udine, Italy.
  • Division of Medical Statistic, Department of Medicine (DMED), University of Udine, Udine, Italy.
  • Department of Neurobiology, Care Sciences and Society, Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
  • Clinic of Obstetrics and Gynecology, Santa Maria Della Misericordia Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy.

Förderung

  • Università degli Studi di Udine

Zitieren

APA

Xodo, S., Da Porto, A., De Martino, M., Del Pin, A., Flaiban, A., Galasso, S., Piccini, S., & Driul, L. (2026). Fetal growth-guided management of gestational diabetes: A retrospective cohort study on insulin requirements and perinatal outcomes. Archives of Gynecology and Obstetrics, 313(1). https://doi.org/10.1007/s00404-026-08467-3

Vancouver

Xodo S, Da Porto A, De Martino M, Del Pin A, Flaiban A, Galasso S, et al. Fetal growth-guided management of gestational diabetes: A retrospective cohort study on insulin requirements and perinatal outcomes. Archives of Gynecology and Obstetrics. 2026;313(1). doi:10.1007/s00404-026-08467-3

BibTeX
@article{Xodo2026,
  author = {Xodo, Serena and Da Porto, Andrea and De Martino, Maria and Del Pin, Annalaura and Flaiban, Asia and Galasso, Silvia and Piccini, Sara and Driul, Lorenza},
  title = {Fetal growth-guided management of gestational diabetes: A retrospective cohort study on insulin requirements and perinatal outcomes},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2026},
  volume = {313},
  number = {1},
  doi = {10.1007/s00404-026-08467-3}
}
Kostenlos starten →